| Literature DB >> 28341840 |
Dame Loveliness T Apaga1,2, Sheila E Dennis1,2,3, Jazelyn M Salvador1,2, Gayvelline C Calacal1,2, Maria Corazon A De Ungria4,5.
Abstract
The potential of Massively Parallel Sequencing (MPS) technology to vastly expand the capabilities of human identification led to the emergence of different MPS platforms that use forensically relevant genetic markers. Two of the MPS platforms that are currently available are the MiSeq® FGx™ Forensic Genomics System (Illumina) and the HID-Ion Personal Genome Machine (PGM)™ (Thermo Fisher Scientific). These are coupled with the ForenSeq™ DNA Signature Prep kit (Illumina) and the HID-Ion AmpliSeq™ Identity Panel (Thermo Fisher Scientific), respectively. In this study, we compared the genotyping performance of the two MPS systems based on 83 SNP markers that are present in both MPS marker panels. Results show that MiSeq® FGx™ has greater sample-to-sample variation than the HID-Ion PGM™ in terms of read counts for all the 83 SNP markers. Allele coverage ratio (ACR) values show generally balanced heterozygous reads for both platforms. Two and four SNP markers from the MiSeq® FGx™ and HID-Ion PGM™, respectively, have average ACR values lower than the recommended value of 0.67. Comparison of genotype calls showed 99.7% concordance between the two platforms.Entities:
Mesh:
Year: 2017 PMID: 28341840 PMCID: PMC5428557 DOI: 10.1038/s41598-017-00510-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Percentage of non-concordance between the HID-Ion PGM™ and MiSeq® FGx™ MPS platforms. Direct Comparison: Concordance evaluation was performed using raw genotype calls reported by the MPS platforms. Indirect Comparison: Concordance evaluation was performed after reverse complementation of all observed genotypes at the 28 SNP loci from the MiSeq® FGx™ platform. Reverse complementation was necessary because the two MPS systems use different nomenclature in reporting SNP calls.
Figure 2Distribution of read counts and median coverage of the SNP markers typed with HID-Ion PGM™.
Figure 3Distribution of read counts and median coverage of the SNP markers typed with MiSeq® FGx™ Forensic Genomics System.
Comparison of genotype calls from the HID-Ion PGM™ and MiSeq® FGx™.
| dbSNP ID | Sample No. | HID Ion | MiSeq FGx | ||||
|---|---|---|---|---|---|---|---|
| Genotype (reads) | ACR | Genotype (reads) | ACR | ||||
| rs1736442 | 1 | C (255) | T (239) | 0.937 | C (12) | T (0) | n/a |
| rs1736442 | 4 | C (88) | T (86) | 0.977 | C (0) | T (12) | n/a |
| rs1736442 | 6 | C (625) | T (619) | 0.990 | C (14) | T (0) | n/a |
| rs1736442 | 104 | C (215) | T (214) | 0.995 | C (12) | T (0) | n/a |
| rs1736442 | 11 | C (265) | T (263) | 0.992 | C (0) | T (17) | n/a |
| rs1736442 | 17 | C (330) | T (364) | 0.907 | C (0) | T (17) | n/a |
| rs1736442 | 18 | C (197) | T (184) | 0.934 | C (0) | T (17) | n/a |
| rs1736442 | 20 | C (272) | T (261) | 0.960 | C (0) | T (17) | n/a |
| rs1736442 | 32 | C (237)) | T (249) | 0.952 | C (22) | T (0) | n/a |
| rs1736442 | 46 | C (366) | T (378) | 0.968 | C (15) | T (0) | n/a |
| rs1736442 | 72 | C (140) | T (124) | 0.886 | C (0) | T (11) | n/a |
| rs1736442 | 87 | C (342) | T (367) | 0.932 | C (24) | T (0) | n/a |
| rs1736442 | 21 | C (162) | T (172) | 0.942 | C (0) | T (0) | n/a |
| rs1031825 | 2 | A (1171) | C (1066) | 0.91 | A (0) | C (11) | n/a |
| rs1031825 | 3 | A (909 | C (841) | 0.925 | A (0) | C (15) | n/a |
| rs1031825 | 5 | A (288) | C (278) | 0.965 | A (13) | C (0) | n/a |
| rs1031825 | 57 | A (221) | C (203) | 0.919 | A (23) | C (0) | n/a |
| rs1031825 | 58 | A (326) | C (298) | 0.914 | A (12) | C (0) | n/a |
| rs1031825 | 82 | A (388) | C (354) | 0.912 | A (0) | C (22) | n/a |
| rs1031825 | 93 | A (468) | C (425) | 0.908 | A (0) | C (14) | n/a |
| rs1031825 | 6 | A (908) | C (839) | 0.924 | A (0) | C (0) | n/a |
| rs1031825 | 53 | A (525) | C (443) | 0.844 | A (0) | C (0) | n/a |
| rs10776839 | 1 | G (62) | T (347) | 0.179 | G(0) | T (253) | n/a |
| rs10776839 | 21 | G (176) | T (765) | 0.230 | G(0) | T (172) | n/a |
| rs10776839 | 33 | G (109) | T (608) | 0.179 | G(0) | T (332) | n/a |
| rs10776839 | 44 | G (131) | T (604) | 0.217 | G(0) | T (402) | n/a |
| rs10776839 | 56 | G (330) | T (1601) | 0.206 | G(0) | T (326) | n/a |
| rs10776839 | 65 | G(124) | T (788) | 0.157 | G(0) | T (286) | n/a |
| rs10776839 | 79 | G (135) | T (1037) | 0.130 | G(0) | T (322) | n/a |
| rs2040411 | 32 | A (112) | G (1103) | 0.102 | A (943) | G (1000) | 0.943 |
| rs2040411 | 120 | A (30) | G (327) | 0.092 | A (416) | G (397) | 0.954 |
| rs560681 | 63 | A (262) | G (248) | 0.947 | A (12) | G (826) | 0.015 |
| rs10488710 | 6 | C (300) | G (304) | 0.987 | C (0) | G (0) | n/a |
| rs1528460 | 19 | C (621) | T (592) | 0.953 | C (0) | T (22) | n/a |
| rs2342747 | 54 | A (112) | G (119) | 0.941 | A (83) | G (26) | 0.313 |
| rs1382387 | 130 | A (169) | C (192) | 0.880 | A (55) | C (1095) | 0.050 |
Figure 4Allele Coverage Ratio of SNPs from the HID-Ion PGM™ and the MiSeq® FGx™ MPS platforms. Gray line marks the 0.67 ACR threshold for balanced heterozygous alleles.